Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 39,744	$ 77,258
Accounts receivable	17	200
Prepaid expenses, deposits, and other current assets	4,165	5,179
Total current assets	43,926	82,637
Fixed assets, net	2,451	1,585
Operating lease right-of-use assets	3,037
Intangible assets, net	3,445	2,029
Other assets	1,121	725
Total assets	53,980	86,976
Current liabilities:
Accounts payable	2,704	3,299
Accrued expenses and other current liabilities	3,705	4,259
Operating lease liabilities, current portion	1,141
Senior Secured Convertible Notes - at fair value	33,650
Total current liabilities	41,200	7,558
Operating lease liabilities, less current portion	1,846
Total liabilities	43,046	7,558
Commitments and contingencies (Note 12)
Stockholders’ Equity:
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,205,759 at December 31, 2022 and 1,113,919 shares at December 31, 2021	2,695	2,419
Common stock, $0.001 par value. Authorized, 250,000,000 shares; 94,510,537 and 86,367,845 shares outstanding as of December 31, 2022 and December 31, 2021, respectively	95	86
Additional paid-in capital	216,106	198,071
Accumulated deficit	(228,169)	(138,910)
Treasury stock	(408)
Total PAVmed Inc. Stockholders’ Equity	(9,681)	61,666
Noncontrolling interests	20,615	17,752
Total Stockholders’ Equity	10,934	79,418
Total Liabilities and Stockholders’ Equity	$ 53,980	$ 86,976